Delivery system for ocular implant

Patent metadata

Field	Value
Publication number	US-10912676-B2
Application number	US-201815912040-A
Country	US
Kind code	B2
Filing date	Mar 5, 2018
Priority date	Apr 24, 2012
Publication date	Feb 9, 2021
Grant date	Feb 9, 2021

Abstract

A delivery system is disclosed which can be used to deliver an ocular implant into a target location within the eye via an ab interno procedure. In some embodiments, the implant can provide fluid communication between the anterior chamber and the suprachoroidal or supraciliary space while in an implanted state. The delivery system can include a proximal handle component and a distal delivery component. In addition, the proximal handle component can include an actuator to control the release of the implant from the delivery component into the target location in the eye.

First claim

The invention claimed is:

1. An eye treatment system, comprising:
a delivery system for delivering an ocular implant into an eye, the delivery system comprising:
a delivery portion at least partially configured to releasably couple to an ocular implant, the delivery portion including a retractable guidewire that fits through an inner lumen of the ocular implant;
wherein the guidewire includes at least one curved section for providing an interference fit between the guidewire and the inner lumen of the ocular implant when the ocular implant is mounted on the guidewire to assist in retaining the implant on the guidewire during delivery into the eye wherein the curved section comprises an s-shape or a sinusoidal shape; and
an actuator that actuates to cause the ocular implant coupled to the delivery portion to release from the delivery portion upon actuation of the actuator.

2. The eye treatment system of claim 1 , wherein the delivery portion further includes a sheath positioned axially over at least a portion of the guidewire.

3. The eye treatment system of claim 1 , wherein, when the implant has been delivered into the eye, actuation of the actuator causes the guidewire to withdraw from the ocular implant in a proximal direction.

4. The eye treatment system of claim 1 , wherein the delivery portion further includes a sheath positioned axially over at least a portion of the guidewire and wherein a distal end of the sheath abuts a proximal end of an ocular implant when the ocular implant is positioned on the guidewire, and wherein the distal end of the sheath prevents the ocular implant from moving toward a handle portion of the delivery system as the guidewire withdraws in a proximal direction.

5. The eye treatment system of claim 1 , wherein the guidewire includes at least one inner lumen.

6. The eye treatment system of claim 5 , wherein the guidewire includes at least one opening that provides fluid communication between the inner lumen of the guidewire and an area surrounding the guidewire.

7. The eye treatment system of claim 6 , wherein the area surrounding the guidewire comprises an inner lumen of an ocular implant.

8. The eye treatment system of claim 1 , wherein the delivery system includes at least one fluid delivery feature which delivers fluid from a fluid source and into an inner lumen of the guidewire.

9. The eye treatment system of claim 8 , wherein the fluid from the fluid source includes one or more of a viscoelastic, a drug and a stem cell.

10. The eye treatment system of claim 1 , wherein the ocular implant is formed of a tubular structure having an internal lumen.

11. The eye treatment system of claim 1 , wherein the ocular implant is configured to drain fluid from an anterior chamber of an eye to a supraciliary space of an eye.

12. The eye treatment system of claim 1 , wherein a distal portion of the guidewire is configured to separate a ciliary body of the eye from a sclera of the eye.

13. The eye treatment system of claim 1 , wherein the actuator includes a mechanism that includes a spring, the spring being coupled to the guidewire.

14. The eye treatment system of claim 13 , wherein actuation of the actuator causes the spring to move the guidewire between a first position and a second position relative to a handle portion of the delivery system.

15. The eye treatment system of claim 14 , wherein actuation of the actuator causes the spring to move the guidewire in a proximal direction relative to a handle portion of the delivery system.

16. The eye treatment system of claim 1 , wherein the curved portion of the guidewire has a nominal longitudinal axis and one or more wire peaks separated from the nominal longitudinal axis, wherein each of the peaks contacts an inner surface of the ocular implant to assist in retaining the implant on the guidewire during delivery into the eye.

17. The eye treatment system of claim 1 , further comprising a dampener coupled to a handle portion of the delivery system, the dampener adapted to dampen retraction of the guidewire upon actuation of the actuator.

18. The eye treatment system of claim 1 , wherein the delivery system further comprises a proximal handle portion coupled to the delivery portion.

Assignees

• Alcon Inc

Inventors

• Schaller Michael
• Lari David
• Clauson Luke
• White Nathan
• Lilly Richard S
• Newell Matthew
• Ahmed Iqbal Ike K

Classifications

• A61M2005/206

  With automatic needle insertion · CPC title

• A61M2025/09183

  having tools at the distal tip · CPC title

• A61F9/00781 Primary

  Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002) · CPC title

• A61F2/95

  Instruments specially adapted for placement or removal of stents or stent-grafts · CPC title

• A61M5/3257

  Semi-automatic sleeve extension, i.e. in which triggering of the sleeve extension requires a deliberate action by the user, e.g. manual release of spring-biased extension means · CPC title